MartÃn-Carrasco, C.; Delgado-Bonet, P.; Tomeo-MartÃn, B.D.; Pastor, J.; de la Riva, C.; Palau-Concejo, P.; del Castillo, N.; GarcÃa-Castro, J.; Perisé-Barrios, A.J.
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. Vet. Sci. 2022, 9, 327.
https://doi.org/10.3390/vetsci9070327
AMA Style
MartÃn-Carrasco C, Delgado-Bonet P, Tomeo-MartÃn BD, Pastor J, de la Riva C, Palau-Concejo P, del Castillo N, GarcÃa-Castro J, Perisé-Barrios AJ.
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. Veterinary Sciences. 2022; 9(7):327.
https://doi.org/10.3390/vetsci9070327
Chicago/Turabian Style
MartÃn-Carrasco, Clara, Pablo Delgado-Bonet, Beatriz Davinia Tomeo-MartÃn, Josep Pastor, Claudia de la Riva, Paula Palau-Concejo, Noemà del Castillo, Javier GarcÃa-Castro, and Ana Judith Perisé-Barrios.
2022. "Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients" Veterinary Sciences 9, no. 7: 327.
https://doi.org/10.3390/vetsci9070327
APA Style
MartÃn-Carrasco, C., Delgado-Bonet, P., Tomeo-MartÃn, B. D., Pastor, J., de la Riva, C., Palau-Concejo, P., del Castillo, N., GarcÃa-Castro, J., & Perisé-Barrios, A. J.
(2022). Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients. Veterinary Sciences, 9(7), 327.
https://doi.org/10.3390/vetsci9070327